3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Blood Specimen Collection
32
Surveys and Questionnaires
24
Radiotherapy
12
Gene Expression Profiling
12
Drug Therapy
12
Surgical Procedures, Operative
11
Bronchoscopy
10
Magnetic Resonance Spectroscopy
9
Immunotherapy
9
Immunohistochemistry
9
Tomography, X-Ray Computed
8
Specimen Handling
8
Observation
8
Amplified Fragment Length Polymorphism Analysis
8
Polymerase Chain Reaction
7
pembrolizumab
6
Psychiatric Rehabilitation
6
Interviews as Topic
6
Carboplatin
6
Thoracic Surgery, Video-Assisted
5
Reverse Transcriptase Polymerase Chain Reaction
5
Microarray Analysis
5
Liquid Biopsy
5
Chemoradiotherapy
5
Bevacizumab
5
durvalumab
4
Therapeutics
4
Paclitaxel
4
Nivolumab
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lung Neoplasms
×
Biological Therapy
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled